Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
$0.00
$0.00
$0.00
$0.00
N/AN/A2,329 shsN/A
AKSY
Aksys
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Avitar Inc. stock logo
AVTI
Avitar
$0.00
$0.00
$0.00
N/AN/AN/AN/A
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
0.00%0.00%0.00%0.00%-83.33%
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
0.00%0.00%+100.00%+100.00%+100.00%
AKSY
Aksys
0.00%0.00%0.00%0.00%0.00%
Avitar Inc. stock logo
AVTI
Avitar
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
$0.00
$0.00
$0.00
$0.00
N/AN/A2,329 shsN/A
AKSY
Aksys
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Avitar Inc. stock logo
AVTI
Avitar
$0.00
$0.00
$0.00
N/AN/AN/AN/A
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
0.00%0.00%0.00%0.00%-83.33%
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
0.00%0.00%+100.00%+100.00%+100.00%
AKSY
Aksys
0.00%0.00%0.00%0.00%0.00%
Avitar Inc. stock logo
AVTI
Avitar
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
0.00
N/AN/AN/A
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
0.00
N/AN/AN/A
AKSY
Aksys
0.00
N/AN/AN/A
Avitar Inc. stock logo
AVTI
Avitar
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
$270KN/AN/AN/AN/AN/A
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
N/AN/AN/AN/AN/AN/A
AKSY
Aksys
N/AN/AN/AN/AN/AN/A
Avitar Inc. stock logo
AVTI
Avitar
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
-$510KN/A0.00N/AN/AN/AN/AN/AN/A
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
N/AN/A0.00N/AN/AN/AN/AN/A
AKSY
Aksys
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Avitar Inc. stock logo
AVTI
Avitar
N/AN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
N/AN/AN/AN/AN/A
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
N/AN/AN/AN/AN/A
AKSY
Aksys
N/AN/AN/AN/AN/A
Avitar Inc. stock logo
AVTI
Avitar
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
N/A
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
N/A
AKSY
Aksys
N/A
Avitar Inc. stock logo
AVTI
Avitar
N/A

Insider Ownership

CompanyInsider Ownership
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
34.11%
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
17.40%
AKSY
Aksys
3.80%
Avitar Inc. stock logo
AVTI
Avitar
7.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Advanced Biomedical Technologies, Inc. stock logo
ABMT
Advanced Biomedical Technologies
20N/AN/ANot Optionable
Alliqua BioMedical, Inc. stock logo
ADYX
Alliqua BioMedical
6N/AN/ANot Optionable
AKSY
Aksys
87N/AN/ANot Optionable
Avitar Inc. stock logo
AVTI
Avitar
36N/AN/ANot Optionable

Recent News About These Companies

Avatar World Codes (July 2024)
Fortnite Avatar event quests and Elements rewards
Avatar Outfit Creator Codes (April 2024)
Avatar 3 Release Date Confirmed by James Cameron

Media Sentiment Over Time

Advanced Biomedical Technologies stock logo

Advanced Biomedical Technologies OTCMKTS:ABMT

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.

Alliqua BioMedical stock logo

Alliqua BioMedical OTCMKTS:ADYX

$0.0002 0.00 (0.00%)
As of 10/17/2025

Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.

Aksys OTCMKTS:AKSY

Aksys Ltd. provides hemodialysis products and services for patients suffering from end-stage renal disease, known as chronic kidney failure. The company offers an automated personal hemodialysis system, known as the Aksys PHD, a Personal Hemodialysis System (PHD System), which is designed to enable patients to perform frequent hemodialysis at alternate sites, such as their own homes. The PHD System is designed to monitor, during the treatment, various vital statistics, including the patient's blood flow rate, the amount of water removed from the patient, the length of the treatment session, and other parameters. It also evaluates the performance of the artificial kidney in removing toxins from the patient's blood prior to each treatment, as well as automatically evaluates the water treatment filters and indicates whether a replacement is required and verifies that safety systems, sensors, and alarms are operating correctly. Aksys Ltd. also provides various services, including the delivery and installation of the PHD System; technical services, including maintenance and repair of the PHD System; delivery of consumables used in dialysis, such as the water purification components and dialysate concentrate; and artificial kidney, and arterial and venous blood tubing. The company markets its products and services, primarily to healthcare providers, such as hospitals, dialysis clinics, managed care organizations, and nephrology physician groups in the United States, the United Kingdom, and Japan. Aksys Ltd. was founded in 1991 and is headquartered in Lincolnshire, Illinois.

Avitar stock logo

Avitar OTCMKTS:AVTI

Avitar, Inc. is a holding company which through its subsidiaries designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine such as crack; marijuana; and methamphetamines, including meth and ecstasy. The company also provides foam disposable products including medical-grade hydrophilic polyurethane foam disposables such as wound dressings comprising Hydrasorb, a wound dressing product for exudating wounds; and various custom foam products comprising a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. In addition, it develops specialty wound dressings for the cardiac catheter lab market, as well as the Illizarov Dressing used for dressing external bone fixators in orthopedic procedures. The company markets its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies, schools, and corporations through direct sales force and strategic partners, as well as through a network of distributors. Avitar, Inc. was founded in 1986 and is based in Canton, Massachusetts with Additional office in Calgary, Canada.